Killer immunoglobulin-like receptor genotype may distinguish immunodeficient HIV-infected patients resistant to immune restoration diseases associated with herpes virus infections [1]

Journal of Acquired Immune Deficiency Syndromes

Volumn 45, Issue 3, 2007, Pages 359-361

  Price, Patricia ^a,b   Witt, Campbell ^a   Santis, Dianne De ^a,b   French, Martyn A ^a,b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN RECEPTOR; KILLER IMMUNOGLOBULIN LIKE RECEPTOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG;

CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HERPES VIRUS INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LETTER; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CYTOMEGALOVIRUS INFECTIONS; GENE FREQUENCY; GENOTYPE; HERPESVIRIDAE INFECTIONS; HUMANS; IMMUNE SYSTEM DISEASES; KILLER CELLS, NATURAL; RECEPTORS, IMMUNOLOGIC;

EID: 34347336508     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31805b82a1     Document Type: Letter

References (16)

1. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS. 2004;18:1615-1627.
2. French MA. Disorders of immune reconstitution in HIV patients responding to antiretroviral therapy. Current HIV/AIDS Reports. 2007;4:16-21.
3. Rauz S, Murray PI. Changing patterns of HIV related ocular disease. Sex Transm Infect. 1999;75:18-20.
4. French MA, Mallal SA, Dawkins RL. Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS. 1992;6:1293-1297.
5. Bourgarit A, Carcelain G, Martinez V, et al. Explosion of tuberculin-specific Th1-responses induced immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS. 2006;20:F1-F7.
6. Domingo P, Torres OH, Ris J, et al. Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with HIV type-1 infection. Am J Med. 2001;110:605-609.
7. Bower M, Nelson M, Young AM, et al. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol. 2005;23:5224-5228.
8. Clark BM, Krueger RG, Price P, et al. Compartmentalization of the immune response in varicella zoster virus immune restoration disease causing transverse myelitis. AIDS. 2004;18:1218-1221.
9. Price P, Morahan G, Huang D, et al. Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS. 2002;16:2043-2047.
10. Henel G, Singh K, Cui D, et al. Uncoupling of T-cell effector functions by inhibitory killer immunoglobulin-like receptors. Blood. 2006;107:4449-4457.
11. Gaudieri S, DeSantis D, McKinnon E, et al. Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression. Genes Immun. 2005;6:683-690.
12. Cook M, Briggs D, Craddock C, et al. Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation. Blood. 2006;107:1230-1232.
13. Martin MP, Gao X, Lee JH, et al. Epistatic interaction between KIR3DS1 and HLA-Bdelays the progression to AIDS. Nat Genet. 2002;31:429-434.
14. Price P, Keane NM, Stone SF, et al. MHC haplotypes affect the expression of opportunistic infections in HIV patients. Hum Immunol. 2001;62:157-164.
15. Sun JY, Gaidulis L, Miller MM, et al. Development of a multiplex PCR-SSP method for killer-cell immunoglobulin-like receptor genotyping. Tissue Antigens. 2004;64:462-468.
16. Scalzo AA, Wheat R, Dubbelde C, et al. Molecular genetic characterization of the distal NKC recombination hotspot and putative murine CMV resistance control locus. Immunogenetics. 2003;55:370-378.